Abstract #711 A Case of Late Onset Polyglandular Autoimmune Syndrome

2018 ◽  
Vol 24 ◽  
pp. 156-157
Author(s):  
Mingxue Arguello ◽  
Ali Mrad
2005 ◽  
Vol 11 ◽  
pp. 85
Author(s):  
Allison Elise Kerr ◽  
Wolali Odonkor ◽  
Gail Nunlee-Bland ◽  
Juanita Archer ◽  
Anitha Kolukula ◽  
...  

2020 ◽  
Vol 158 (6) ◽  
pp. S-324-S-325
Author(s):  
Takahisa Furuta ◽  
Takuma Kagami ◽  
Mihoko Yamade ◽  
Takahiro Suzuki ◽  
Tomohiro Higuchi ◽  
...  

Reports ◽  
2021 ◽  
Vol 4 (1) ◽  
pp. 1
Author(s):  
Juan Luis Fernández-Morera ◽  
Alfredo Renilla González ◽  
Carmen Elena Calvo Rodríguez ◽  
Judit Romano-García

Background: CTLA-4 and PD-1L are novel immune checkpoint targets for cancer treatment with specific side effects such as autoimmune diseases. Less frequently, the presence of several autoimmune diseases in the same patient has been described. In this communication, we illustrate the case of a 45-year-old patient with a previous diagnosis of advanced cancer that, after starting treatment with this immunotherapy, developed in the following months autoimmune diabetes, lymphocytic hypophysitis, and a Hashimoto thyroiditis in an abrupt and intense manner that would correspond to an autoimmune polyglandular disease. Discussion: The activation of autoimmunity and associated diseases is increasing in parallel with augmented indication of these immunotherapeutic treatments in cancer patients. A closer follow-up of these patients could be necessary for an optimal approach to this type of pathology. Conclusions: Different autoimmune diseases can converge in the same patient when immunotherapy for cancer is indicated to boost immune response against tumor, caused by altering immune tolerance.


2005 ◽  
Vol 32 (12) ◽  
pp. 1044-1047 ◽  
Author(s):  
Michael Sand ◽  
Falk Georges Bechara ◽  
Daniel Sand ◽  
Georg Moussa ◽  
Markus Stücker ◽  
...  

Nephron ◽  
1996 ◽  
Vol 72 (3) ◽  
pp. 497-498 ◽  
Author(s):  
Moses Elisaf ◽  
Haralampos Pappas ◽  
Kostas C. Siamopoulos

2009 ◽  
Vol 20 ◽  
pp. S43
Author(s):  
Elsa Sousa ◽  
Ana João Sá ◽  
Diana Valadares ◽  
Sara Marques ◽  
Rui Carvalho ◽  
...  

Author(s):  
Luiza Cottas ◽  
Maria Borges ◽  
Lívia Oliveira ◽  
Ana Resende ◽  
Meire Ataíde ◽  
...  

AbstractPolyglandular autoimmune syndrome type II (PGA-II) is a rare immunoendocrinopathy syndrome characterized by the occurrence of autoimmune Addison disease along with diabetes mellitus type 1 and/or autoimmune thyroid disease. Here, we report the case of a 23-year-old female with PGA-II who was followed up at the dermatology and endocrinology clinics of the Universidade Federal do Triângulo Mineiro, located in the state of Minas Gerais, Brazil. First, the patient presented diffuse skin hyperpigmentation, vitiligo; and in sequence, due to vomiting, appetite and weight loss, hypoglycemia, amenorrhea, and galactorrhea, the patient was then diagnosed with PGA-II. The patient also presented intense hyperprolactinemia due to primary hypothyroidism. The late diagnosis of PGA-II is frequent because the disorder is uncommon and has non-specific clinical manifestations. This report emphasizes the significance of a timely diagnosis and appropriate treatment to reduce morbidity and mortality associated with these diseases, especially Addison disease. The present study reports a rare case of a patient with PGA-II with primary amenorrhea associated with hyperprolactinemia.


Sign in / Sign up

Export Citation Format

Share Document